Correlation Between Faron Pharmaceuticals and Primorus Investments

Can any of the company-specific risk be diversified away by investing in both Faron Pharmaceuticals and Primorus Investments at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Faron Pharmaceuticals and Primorus Investments into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Faron Pharmaceuticals Oy and Primorus Investments plc, you can compare the effects of market volatilities on Faron Pharmaceuticals and Primorus Investments and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Faron Pharmaceuticals with a short position of Primorus Investments. Check out your portfolio center. Please also check ongoing floating volatility patterns of Faron Pharmaceuticals and Primorus Investments.

Diversification Opportunities for Faron Pharmaceuticals and Primorus Investments

-0.55

Correlation Coefficient

Faron Pharmaceuticals  Primorus Investments

Excellent diversification

The 3 months correlation between Faron and Primorus is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Faron Pharmaceuticals Oy and Primorus Investments plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Primorus Investments plc and Faron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Faron Pharmaceuticals Oy are associated (or correlated) with Primorus Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Primorus Investments plc has no effect on the direction of Faron Pharmaceuticals i.e., Faron Pharmaceuticals and Primorus Investments go up and down completely randomly.

Pair Corralation between Faron Pharmaceuticals and Primorus Investments

Assuming the 90 days trading horizon Faron Pharmaceuticals Oy is expected to generate 2.6 times more return on investment than Primorus Investments. However, Faron Pharmaceuticals is 2.6 times more volatile than Primorus Investments plc. It trades about 0.15 of its potential returns per unit of risk. Primorus Investments plc is currently generating about -0.05 per unit of risk. If you would invest  18,000  in Faron Pharmaceuticals Oy on October 9, 2024 and sell it today you would earn a total of  2,500  from holding Faron Pharmaceuticals Oy or generate 13.89% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Faron Pharmaceuticals Oy  vs.  Primorus Investments plc

Faron Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Faron Pharmaceuticals Oy has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Faron Pharmaceuticals is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Primorus Investments plc

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Primorus Investments plc are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Primorus Investments unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Faron Pharmaceuticals and Primorus Investments

The main advantage of trading using opposite Faron Pharmaceuticals and Primorus Investments positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Faron Pharmaceuticals position performs unexpectedly, Primorus Investments can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Primorus Investments will offset losses from the drop in Primorus Investments' long position.

The idea behind Faron Pharmaceuticals Oy and Primorus Investments plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.